Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction

Aim. To study diagnostic and prognostic role of hyperglycemia in patients with acute phase of myocardial infarction (MI), according to five-year follow(up results. Material and methods. In total, 130 men aged 47,1±1,7 years were examined. In 75 patients, glucose level in venous blood was measured du...

Full description

Saved in:
Bibliographic Details
Main Authors: I. L. Telkova, R. S. Karpov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1586
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699438454374400
author I. L. Telkova
R. S. Karpov
author_facet I. L. Telkova
R. S. Karpov
author_sort I. L. Telkova
collection DOAJ
description Aim. To study diagnostic and prognostic role of hyperglycemia in patients with acute phase of myocardial infarction (MI), according to five-year follow(up results. Material and methods. In total, 130 men aged 47,1±1,7 years were examined. In 75 patients, glucose level in venous blood was measured during acute MI phase, one week later, and after 21-26 days. Five(year follow-up data were available for 85,3% of the participants. Results. All patients were divided into two clinical groups (cG), according to glucose level in acute MI phase: cG I (n=43) and cG II (n=32), with glucose levels of 4,74±0,85 mM/l and 8,35±2,50 mM/l, respectively (p<0,00001). Five(year death rates in cG II and cG I were 66,6% and 48,6%, respectively (x2=2,79; p>0,05). Among patients with adverse outcomes, individuals with hypoglycemia during acute MI phase were prevalent (14,3% vs 7,1% in cG I). Maximal five(year survival was associated with isoglycemia and/or mild hyperglycemia. In patients with glucose level >7 mM/l, death HR was 1,56 (CI 1,14:3,46; p<0,05). For hypoglycaemia (<3,9 mM/l), death HR was maximal - 1,74 (CI 1,14:3,46; p<0,05). Conclusion. In acute MI phase, transitory hyperglycemia was registered in 44,4% of the patients, hypoglycemia – in 11,3%, and isoglycemia – in 44,3%. Hyper- and hypoglycemia were associated with aggravated clinical course, structural and metabolic myocardial disturbances, and adverse prognosis.
format Article
id doaj-art-8e624f83867e4bfc8fab39cba8a35f1a
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 1970-01-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-8e624f83867e4bfc8fab39cba8a35f1a2025-08-20T03:18:34Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-016846511303Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarctionI. L. Telkova0R. S. Karpov1Research Institute of Cardiology, Tomsk Scientific Center, Siberian Branch, Russian Academy of Medical Sciences, TomskResearch Institute of Cardiology, Tomsk Scientific Center, Siberian Branch, Russian Academy of Medical Sciences, TomskAim. To study diagnostic and prognostic role of hyperglycemia in patients with acute phase of myocardial infarction (MI), according to five-year follow(up results. Material and methods. In total, 130 men aged 47,1±1,7 years were examined. In 75 patients, glucose level in venous blood was measured during acute MI phase, one week later, and after 21-26 days. Five(year follow-up data were available for 85,3% of the participants. Results. All patients were divided into two clinical groups (cG), according to glucose level in acute MI phase: cG I (n=43) and cG II (n=32), with glucose levels of 4,74±0,85 mM/l and 8,35±2,50 mM/l, respectively (p<0,00001). Five(year death rates in cG II and cG I were 66,6% and 48,6%, respectively (x2=2,79; p>0,05). Among patients with adverse outcomes, individuals with hypoglycemia during acute MI phase were prevalent (14,3% vs 7,1% in cG I). Maximal five(year survival was associated with isoglycemia and/or mild hyperglycemia. In patients with glucose level >7 mM/l, death HR was 1,56 (CI 1,14:3,46; p<0,05). For hypoglycaemia (<3,9 mM/l), death HR was maximal - 1,74 (CI 1,14:3,46; p<0,05). Conclusion. In acute MI phase, transitory hyperglycemia was registered in 44,4% of the patients, hypoglycemia – in 11,3%, and isoglycemia – in 44,3%. Hyper- and hypoglycemia were associated with aggravated clinical course, structural and metabolic myocardial disturbances, and adverse prognosis.https://cardiovascular.elpub.ru/jour/article/view/1586myocardial infarctionhyperglycemiadiagnostic valueprognosis
spellingShingle I. L. Telkova
R. S. Karpov
Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
Кардиоваскулярная терапия и профилактика
myocardial infarction
hyperglycemia
diagnostic value
prognosis
title Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
title_full Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
title_fullStr Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
title_full_unstemmed Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
title_short Diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
title_sort diagnostic and prognostic role of hyperglycemia in acute phase of myocardial infarction
topic myocardial infarction
hyperglycemia
diagnostic value
prognosis
url https://cardiovascular.elpub.ru/jour/article/view/1586
work_keys_str_mv AT iltelkova diagnosticandprognosticroleofhyperglycemiainacutephaseofmyocardialinfarction
AT rskarpov diagnosticandprognosticroleofhyperglycemiainacutephaseofmyocardialinfarction